Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Spectranetics Corp.

Jul 2010
Colorado Springs, Colo.-based Spectranetics Corp., a single-use medical device manufacturer, has announced its clinical trial plans related to the treatment of in-stent restenosis in arteries above the knee. Currently, there are no devices cleared or approved by the FDA to treat in-stent restenosis. The company has planned to initiate a multicenter randomized trial in the US to compare laser ablation followed by adjunctive balloon angioplasty with balloon angioplasty alone.

laser ablation
The removal of material from a surface by high intensity pulsed or CW laser radiation emission.
adjunctive balloon angioplastyAmericasangioplastyBiophotonicsBusinessclinical trialFDAin-stent restenosiskneelaser ablationmedicalRapidScanrestenosisSpectranetics Corp.USlasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.